News

Show
news from

Freeline Announces Orphan Drug Designations for FLT201 for the Treatment of Gaucher Disease

Freeline to Participate in Upcoming Investor Conferences in September 2021

Purespring strengthens senior leadership with appointment of Chief Medical Officer and Chief Development Officer

Freeline Appoints Michael J. Parini as Chief Executive Officer and Reports Second Quarter 2021 Financial Results

Freeline Provides Executive Leadership Team Update; Company to Provide Corporate Update and Second Quarter 2021 Financial Results on Monday, August 16

Freeline Announces Executive Leadership Changes

Load more

Search